‘AeroNabs’ promise powerful, inhalable protection against COVID-19
As COVID-19 hit and UCSF labs shut down, the Manglik and Walter labs got to work using nanobodies (camelid-derived antibodies) to counter the SARS-CoV-2 spike protein. Biophysics student Bryan Faust is one of the co-first authors on the resulting study. Bryan and other Manglik lab members are also part of the larger QBI Coronavirus Research Group Structural Biology Consortium, which knits together UCSF structural biology labs and determined the X-ray and CryoEM structures that revealed the basis for the potency of the nanobodies in atomic detail. The resulting preprint represents an enormous team effort spanning our shelter-in-place order to our new normal and demonstrates that the nanobodies are highly expressed, are extremely stable, and can neutralize SARS-CoV-2 in cell culture.